Equine Herpes Virus-1. A clinician’s perspective.

PDF (English)
Publicado: Jul 9, 2023
Actualizado: 2023-07-09
Versiones:
2023-07-09 (2)
DOI: https://doi.org/10.12681/jhvms.29907
P Tyrnenopoulou
Clinic of Surgery, Faculty of Veterinary Science, School of Health Sciences, University of Thessaly, Greece
https://orcid.org/0000-0003-2325-3791
N Diakakis
School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece
https://orcid.org/0000-0002-4826-641X
Resumen

Equid herpesvirus type 1 (EHV-1) is a common pathogen of horses with worldwide distribution. In light of recent outbreaks reported across Europe and United States of America, the contagious nature of this disease is highlighted and re-evaluation of diagnostic procedures, treatment modalities and biosecurity protocols is imperative. This review provides an overview of the epidemiology, current treatment protocols and prognosis for EHV-1-associated syndromes, with an emphasis on the neuropathogenic strain of EHV-1.

Article Details
  • Sección
  • Review Articles
Creative Commons License

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.

Authors who publish with this journal agree to the following terms:

· Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution Non-Commercial License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

· Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g. post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

· Authors are permitted and encouraged to post their work online (preferably in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

Descargas
Los datos de descargas todavía no están disponibles.
Citas
Allen GP (2008) Risk factors for development of neurologic disease after
experimental exposure to equine herpesvirus-1 in horses. Am J Vet Res
(12):1595-1600.
Allen GP, Kydd JH, Slater JD and Smith KC (2004) Equid herpesvirus 1
(EHV-1) and equid herpesvirus 4 (EHV-4) infections In: Infectious Diseases of Livestock, Eds: J.A.W. Coetzer and R.C. Tustin, Oxford Press,
Cape Town: pp 829-859.
Altan E, Li Y, Sabino-Santos Jr G, Sawaswong V, Barnum S, Pusterla N, Deng
X, Delwart E (2019) Viruses in horses with neurologic and respiratory
diseases. Viruses 11(10): 942
Autio K, Rassnick KM, Bedford-Guaus SJ (2007) Chemotherapy during pregnancy: a review of the literature. Vet Comp Oncol 5:61-75.
Back H, Weld J, Walsh C, Cullinane A (2019) Equine Rhinitis A Virus Infection in Thoroughbred Racehorses—A Putative Role in Poor Performance?. Viruses 11(10): 963.
Balasuriya UB, Carossino M, Timoney PJ (2008). Equine viral arteritis: a respiratory and reproductive disease of significant economic importance to
the equine industry. Equine Vet Educ 30(9):497-512.
Barba M, Fairbanks EL, Daly JM (2019) Equine viral encephalitis: prevalence,
impact, and management strategies. Vet Med: Research and Reports Vet
Med (Auckl) 10:99.
Bazanow BA, Fracka AB, Jackulak NA, Staroniewicz ZM, Ploch SM (2014)
A 34-year retrospective study of equine viral abortion in Poland Pol J Vet
Sci 17:607–12.
Boyle AG, Timoney JF, Newton JR, Hines MT, Waller AS, Buchanan BR
(2018) Streptococcus equi infections in horses: guidelines for treatment,
control, and prevention of strangles—revised consensus statement. J Vet
Intern Med 32(2):633-47.
Bryant NA, Wilkie GS, Russell CA, Compston L, Grafham D, Clissold L,
McLay K, Medcalf L, Newton R, Davison AJ, Elton DM (2018) Genetic
diversity of equine herpesvirus 1 isolated from neurological, abortigenic
and respiratory disease outbreaks Transbound Emerg Dis 65(3):817-32.
Burgess BA, Tokateloff N, Manning S, Lohmann K, Lunn DP, Hussey SB,
Morley PS (2012) Nasal Shedding of Equine Herpesvirus‐1 from Horses
in an Outbreak of Equine Herpes Myeloencephalopathy in Western Canada. J Vet Intern Med 26(2):384-92.
Burrows R and Goodridge D (1973) In vivo and in vitro studies of equine
rhinopneumonitis strains In Equine Infectious Diseases III, pp. 306–321
Eds. J. T. Bryans and H. Gerber Karger, Basel.
Carmichael RJ, Whitfield C, Maxwell LK (2013) Pharmacokinetics of
ganciclovir and valganciclovir in the adult horse. J Vet Pharmacol Ther
(5):441-9. doi: 10.1111/ jvp.12029
Castro ER, Arbiza J (2017) Detection and genotyping of equid herpesvirus 1 in
Uruguay. Rev Sci Tech 36:799-806.
Crabb BS, Studdert MJ (1993) Epitopes of glycoprotein G of equine herpesviruses 4 and 1 located near the C termini elicit type-specific antibody
responses in the natural host. J Virol 67(10):6332-8.
Damiani AM, de Vries M, Reimers G, Winkler S, Osterrieder N (2014) A severe equine herpesvirus type 1 (EHV-1) abortion outbreak caused by a
neuropathogenic strain at a breeding farm in northern Germany. Vet Microbiol 172(3-4):555-562.
Davison AJ, Eberle R, Ehlers B, Hayward GS, McGeoch DJ, Minson AC, Pellett PE, Roizman B, Studdert MJ, Thiry E (2009) The order herpesvirales.
Archives of virology 154(1):171-7.
Dimock WW (1940) The diagnosis of virus abortion in mares J Am Vet Med
Assoc 96, 665–666.
Dimock WW, Edwards PR (1933) Is there a filterable virus of abortion in
mares? Ky Agric Exp Stn Bull 333:291-301.
Dixon RJ, Hartley WJ, Hutchins DR, Lepherd EE, Feilen C, Jones RF, Love
DN, Sabine M, Wells AL (1978) Perinatal foal mortality associated with a
herpesvirus. Aus Vet Journal 54(3):103-5.
Edington N, Bridges CG, Huckle A (1985). Experimental reactivation of equid
herpesvirus 1 (EHV 1) following the administration of corticosteroids.
Equine Vet J. 17(5):369-72.
Equine Disease Communication Center (EDCC) (2021) https://www.equinediseasecc.org/alerts [accessed 12 May 2021]
Fédération Equestre Internationale (FEI) (2021) https://inside.fei.org/fei/ehv-1
[accessed 11 May 2021]
Garré B, Gryspeerdt A, Croubels S, De Backer P, Nauwynck H (2009) Evaluation of orally administered valacyclovir in experimentally EHV-1 infected
ponies. Vet Microbiol 135 (3-4):214-21.
Gerst S, Borchers K, Gower SM, Smith KC (2003) Detection of EHV‐1 and
EHV‐4 in placental sections of naturally occurring EHV‐1‐and EHV‐4‐
related abortions in the UK: use of the placenta in diagnosis. Equine Vet
J 35(5):430-3.
Gibson JS, Slater JD, Awan AR, Field HJ (1992) Pathogenesis of equine herpesvirus-1 in specific pathogen-free foals: primary and secondary infections and reactivation. Arch Virol 1;123:351-66.
Gibson JS, Slater JD, Field HJ (1992) The pathogenicity of Ab4p, the sequenced strain of equine herpesvirus-1, in specific pathogen-free foals
Virol 1;189(1):317-9.
Gilger BC (2010) Equine recurrent uveitis: the viewpoint from the USA.
Equine Vet J 2010 42(S37):57-61.
Gilkerson JR, Bailey KE, Diaz-Méndez A, Hartley CA (2015) Update on viral
diseases of the equine respiratory tract. Vet Clin: Equine Pract 31(1):91-
Gilkerson JR, Love DN, Whalley JM (2000) Incidence of equine herpesvirus 1 infection in Thoroughbred weanlings on two stud farms Aust Vet J
(4):277-8.
Göhring LS, Brandes K, Ashton LV, Wittenburg LA, Olea‐Popelka FJ, Lunn
DP, Soboll Hussey G (2017) Anti‐inflammatory drugs decrease infection
of brain endothelial cells with EHV‐1 in vitro. Equine Vet J 49(5):629-36.
Göhring LS, Landolt GA, Morley PS (2010) Detection and management of an
outbreak of equine herpesvirus type 1 infection and associated neurological disease in a veterinary teaching hospital. J Vet Intern Med 24(5):1176-
Göhring LS, Van Maanen C, van Oldruitenborgh‐Oosterbaan MS (2005) Neurological syndromes among horses in The Netherlands a 5 year retrospective survey (1999–2004). Vet Q 27(1):11-20.
Griffith RS, Walsh DE, Myrmel KH, Thompson RW, Behforooz A (1987) Success of L-lysine therapy in frequently recurrent herpes simplex infection.
Dermatology 175(4):183-90.
Grinde B (2013) Herpesviruses: latency and reactivation - viral strategies and
host response J Oral Microbiol 5:10.3402/jom.v3405i3400.22766 doi:
3402/jom.v3405i3400.22766.
Gryspeerdt AC, Vandekerckhove AP, Garré B, Barbé F, Van de Walle GR,
Nauwynck HJ (2010) Differences in replication kinetics and cell tropism
between neurovirulent and non-neurovirulent EHV1 strains during the
acute phase of infection in horses. Veterinary microbiology 142(3-4):242-
Hartley CA, Dynon KJ, Mekuria ZH, El-Hage CM, Holloway SA, Gilkerson
JR (2013) Equine gammaherpesviruses: perfect parasites? Vet Microbiol
(1-2):86-92.
Hartley CA, Wilks CR, Studdert MJ, Gilkerson JR (2005) Comparison of antibody detection assays for the diagnosis of equine herpesvirus 1 and 4
infections in horses. Am J Vet Res 66(5):921-8.
Henninger RW, Reed SM, Saville WJ, Allen GP; Hass GF, Kohn CW, Sofaly C
(2007). Outbreak of neurologic disease caused by equine herpesvirus-1 at
a university equestrian center. J Vet Intern Med 21, 157–165.
Hernandez D, Yeo WM, Brooks MB, Ness SL, Divers TJ, Stokol T (2016)
Effects of various antiplatelet drugs on ex vivo platelet activation induced
by equine herpesvirus type 1. Am J Vet Res 77(12):1366-73.
Hussey GS, Goehring LS, Lunn DP, Hussey SB, Huang T, Osterrieder N,
Powell C, Hand J, Holz C, Slater J (2013) Experimental infection with
equine herpesvirus type 1 (EHV-1) induces chorioretinal lesions. Vet Res
(1):1-5.
Hussey SB, Clark R, Lunn KF, Breathnach C, Soboll G, Whalley JM, Lunn
DP (2006) Detection and quantification of equine herpesvirus-1 viremia
and nasal shedding by real-time polymerase chain reaction. J Vet Diagn
Invest 18(4):335-42.
Ivens P ( 2014) EHM—What every equine practitioner needs to know. Livest
(3):180-5.
Karlin S, Mocarski ES, Schachtel GA (1994) Molecular evolution of herpesviruses: genomic and protein sequence comparisons. Journal of virology
(3):1886-902.
Khusro A, Aarti C, Rivas-Caceres RR, Barbabosa-Pliego A (2020) Equine herpesvirus-I infection in horses: Recent updates on its pathogenicity, vaccination, and preventive management strategies. J Equine V Sci 87:102923.
Kress F (1941) Virus abortus bei der Stute, Wien Tieraerztl Wochenschr
:320.
Kydd JH, Slater J, Osterrieder N, Lunn DP, Antczak DF, Azab W, Balasuriya
U, Barnett C, Brosnahan M, Cook C, Damiani A (2012) Third international havemeyer workshop on equine herpesvirus type 1. Equine Vet J. 44(5):513-7
Kydd JH, Townsend HG, Hannant D (2006) The equine immune response to
equine herpesvirus-1: the virus and its vaccines. Vet Immunol Immunopathol 111(1-2):15-30.
Laval K, Poelaert KC, Van Cleemput J, Zhao J, Vandekerckhove AP, Gryspeerdt AC, Garré B, van der Meulen K, Baghi HB, Dubale HN, Zarak
I (2021) The Pathogenesis and Immune Evasive Mechanisms of Equine
Herpesvirus Type 1. Frontiers in Microbiology Mar 4;12:435.
Lecollinet S, Pronost S, Coulpier M, Beck C, Gonzalez G, Leblond A, Tritz P
(2020) Viral equine encephalitis, a growing threat to the horse population
in Europe?. Viruses 12(1):23.
Long MT (2014) West Nile virus and equine encephalitis viruses: new perspectives. Vet Clin Equine 30(3):523-42.
Lunn DP, Davis-Poynter N, Flaminio MJ, Horohov DW, Osterrieder K, Pusterla N, Townsend HG (2009) Equine herpesvirus-1 consensus statement.
J Vet Intern Med. 23(3):450-61. doi: 10.1111/j.1939-1676.2009.0304.x.
PMID: 19645832.
Ma G, Azab W, Osterrieder N (2013) Equine herpesviruses type 1 (EHV-1)
and 4 (EHV-4)—masters of co-evolution and a constant threat to equids
and beyond Vet microbiol 29;167(1-2):123-34.
Mailoo VJ, Rampes. S (2017) Lysine for herpes simplex prophylaxis. Integr
Med 16(3):42-46.
Manninger R, Csontos J (1941) Virusabortus der Stuten. Dtsch Tierartztl
Wschr 49:105-11.
Marenzoni ML, Lepri E, Proietti PC, Bietta A, Coletti M, Timoney PJ, Passamonti F. (2012) Causes of equine abortion, stillbirth and neonatal death
in central Italy. The Vet Rec 170(10):262.
Maxwell LK, Bentz BG, Bourne DW, et al (2008) Pharmacokinetics of valacyclovir in the adult horse. J Vet Pharmacol Ther 31:312–20
McCann SH, Mumford JA, Binns MM (1995) Development of PCR assays to
detect genetic variation amongst equine herpesvirus-1 isolates as an aid to
epidemiological investigation. J Virol Methods 52(1-2):183-94.
McCartan CG, Russell MM, Wood JL, Mumford JA (1995) Clinical, serological and virological characteristics of an outbreak of paresis and neonatal
foal disease due to equine herpesvirus-1 on a stud farm. Vet Rec 136(1):7-
McFadden AM, Hanlon D, McKenzie RK, Gibson I, Bueno IM, Pulford DJ,
Orr D, Dunowska M, Stanislawek WL, Spence RP, McDonald WL, Munro G, Mayhew IG (2016) The first reported outbreak of equine herpesvirus myeloencephalopathy in New Zealand. N Z Vet J 64(2):125-34. doi:
1080/00480169.2015.1096853.
Mesquita LP, Costa RC, Mesquita LL, Lara MD, Villalobos EM, Mori CM,
Mori E, Howerth EW, Maiorka PC (2021) Pathogenesis of Equid Alphaherpesvirus 1 Infection in the Central Nervous System of Mice. Vet Path
:03009858211020670.
Negussie H, Gizaw D, Tessema TS, Nauwynck HJ (2017) Equine herpesvirus‐1 myeloencephalopathy, an emerging threat of working equids in ethiopia. Transbound Emerging Dis 64(2):389-97.
O’Callaghan DJ, Osterrieder N (2008) Herpesviruses of horses. In: Encyclopedia of Virology. 3rd ed, Academic Press, New York :pp 411-420
Oladunni FS, Horohov DW, Chambers TM (2019) EHV-1: A constant threat to
the horse industry Front Microbiol 3;10:2668.
Osterrieder N, Van de Walle GR (2010) Pathogenic potential of equine alphaherpesviruses: the importance of the mononuclear cell compartment in
disease outcome. Vet microbiol 16;143(1):21-8.
Paillot R, Marcillaud Pitel C, D’ablon X, Pronost S (2016) Equine Vaccines:
How, When and Why? Report of the vaccinology session, french equine
veterinarians association, Reims.
Paillot R, Sutton G, Thieulent C, Marcillaud-Pitel C; Pronost S (2020) New
EHV-1 variant identified Vet Rec 186, 573.
Payne S (2017) Family Hepeviridae. Viruses MDPI: Basel, Switzerland 121-4.
Preziuso S, Sgorbini M, Marmorini P, Cuteri V (2019) Equid alphaherpesvirus
from Italian Horses: Evaluation of the Variability of the ORF30, ORF33,
ORF34 and ORF68 Genes. Viruses 11(9):851.
Pronost S, Cook RF, Fortier G, Timoney PJ, Balasuriya UB (2010) Relationship between equine herpesvirus‐1 myeloencephalopathy and viral genotype. Equine Vet J 42(8):672-4.
Pusterla N, Barnum S, Miller J, Varnell S, Dallap-Schaer B, Aceto H, Simeone
A (2021) Investigation of an EHV-1 outbreak in the United States caused
by a new H752 genotype Pathogens 10(6):747.
Pusterla N, Hussey GS. Equine herpesvirus 1 myeloencephalopathy (2014)
Vet Clin North Am Equine Pract (2014) 30(3):489-506. doi: 10.1016/j.
cveq.2014.08.006. Epub 2014 Oct 7. PMID: 25300635.
Randall CC, Ryden FW, Doll ER & Schell FS (1953) Amer Jour Path 29, 139.
Roizman B (1991) Family Herpesviridae. In: Francki RIB, Fauquet CM,
Knudson DL and Brown F (eds) Classification and nomeclature of viruses. 5th Report of the International Committee on Taxonomy of Viruses
Arch Viral., 2 (suppl) :l03-110.
Saxegaard F (1966) Isolation and identification of equine rhinopneumonitis
virus (equine abortion virus) from cases of abortion and paralysis Nord
Vet Med 18:504-12.
Schulman ML, Kass PH, Becker A, Van der Merwe B (2013) A predictive
model for reproductive performance following abortion in Thoroughbred
mares Vet Rec 172(2):44.
Shiraki K (2018) Antiviral drugs against alphaherpesvirus. Adv Exp Med Biol
; 103–122.
Slater J (2007) Equine herpesviruses. In:. Equine Infectious Diseases. Saunders Elsevier, St. Louis, Missouri, USA: pp 134–153.
Smith KC, Blunden AS, Whitwell KE, Dunn KA, Wales AD (2003) A survey
of equine abortion, stillbirth and neonatal death in the UK from 1988 to
Equine Vet J 35(5):496-501
Smith KL, Li Y, Breheny P, Cook RF, Henney PJ, Sells S, Pronost S, Lu Z,
Crossley BM, Timoney PJ, Balasuriya UB (2012) New real-time PCR assay using allelic discrimination for detection and differentiation of equine
herpesvirus-1 strains with A2254 and G2254 polymorphisms. J Clin Microbiol 50(6):1981-8.
Stasiak K, Dunowska M, Rola J (2020) Outbreak of equid herpesvirus 1 abortions at the Arabian stud in Poland. BMC Vet Res 16(1):1-8.
Stokol T, Serpa PBS, Zahid MN, Brooks MB (2016) Unfractionated and
low-molecular-weight heparin and the phosphodiesterase inhibitors,
IBMX and cilostazol, block ex vivo equid herpesvirus type-1-induced
platelet activation. Front Vet Sci 3:99. doi: 10.3389/fvets.2016.00099.
Studdert MJ, Hartley CA, Dynon K, Sandy JR, Slocombe RR, Charles JA,
Milne ME, Clarke AF, El‐Hage C (2003) Outbreak of equine herpesvirus
type 1 myeloencephalitis: new insights from virus identification by PCR
and the application of an EHV‐1‐specific antibody detection ELISA. Vet
Rec 153(14):417-23.
Sutton G, Thieulent C, Fortier C, Hue ES, Marcillaud-Pitel C, Pléau A, Deslis
A, Guitton E, Paillot R, Pronost S (2020) Identification of a New Equid
Herpesvirus 1 DNA Polymerase (ORF30) Genotype with the Isolation of
a C2254/H752 Strain in French Horses Showing no Major Impact on the
Strain Behaviour Viruses 12(10):1160.
Telford EA, Watson MS, Perry J, Cullinane AA, Davison AJ (1998) The DNA
sequence of equine herpesvirus-4. J Gen Virol 79(5):1197-203.
Traub‐Dargatz JL, Pelzel‐McCluskey AM, Creekmore LH, Geiser‐Novotny
S, Kasari TR, Wiedenheft AM, Bush EJ, Bjork KE (2013) Case–control
study of a multistate equine herpesvirus myeloencephalopathy outbreak. J
Vet Intern Med 27(2):339-46.
Van Cleemput J, Poelaert KC, Laval K, Maes R, Hussey GS, Van den Broeck
W, Nauwynck HJ (2017) Access to a main alphaherpesvirus receptor, located basolaterally in the respiratory epithelium, is masked by intercellular
junctions. Sci Rep 30;7(1):1-5.
Van den Ingh TS, Binkhorst GJ, Kimman TG, Vreeswijk J, Pol JM, Van
Oirschot JT (1990) Aujeszky’s disease in a horse. J Vet Med Series B
(1‐10):532-8.
Van Maanen C, van Oldruitenborgh‐Oosterbaan MS, Damen EA, Derksen
AG (2001) Neurological disease associated with EHV‐1‐infection in a
riding school: clinical and virological characteristics. Equine Vet J 2001
(2):191-196.
Van Maanen C, Willink DL, Smeenk LA, Brinkhof J, Terpstra C. An equine
herpesvirus 1 (EHV1) abortion storm at a riding school (2000) Vet Q
;22(2):83-7.
Vandekerckhove A, Glorieux S, Gryspeerdt A, Steukers L, Duchateau L,
Osterrieder N, Van de Walle G, Nauwynck H (2010) Replication kinetics of neurovirulent versus non-neurovirulent equine herpesvirus type
strains in equine nasal mucosal explants. Journal of General Virology
(8):2019-28.
Vautmans H, European Parliament (2021) https://www.europarl.europa.eu/doceo/document/P-9-2021-001223_EN.html [accessed 26 May 2021]
Walter J, Seeh C, Fey K, Bleul U, Osterrieder N (2013) Clinical observations
and management of a severe equine herpesvirus type 1 outbreak with
abortion and encephalomyelitis. Acta Vet Scand 55(1):1-9.
Walter J, Seeh C, Fey K, Bleul U, Osterrieder N (2013) Clinical observations
and management of a severe equine herpesvirus type 1 outbreak with abortion and encephalomyelitis. Acta Vet Scand 55(1):19. doi: 10.1186/1751-
-55-19. PMID: 23497661; PMCID: PMC3630004.
Westerfield C, Dimock WW (1946) The pathology of equine virus abortion.
Journal of the American Veterinary Medical Association 109:101-11.
Wilson WD (1997) Equine herpesvirus 1 myeloencephalopathy Vet Clin North
Am Equine Pract 13: 53–72.
Xie J, Tong P, Zhang L, Ren M, Song X, Jia C, Palidan N, Zhang L, Kuang L
(2021) First detection and genetic characterization of equid herpesvirus 2,
, and 5 in China. Arch Virol 166(5):1421-6
Artículos más leídos del mismo autor/a